These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 556350)

  • 1. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.
    Fukushima M; Ikenaka K; Shirasaka T; Fujii S
    Gan; 1979 Feb; 70(1):47-53. PubMed ID: 556350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characteristics of a 5-fluorouracil-resistant subline of P388 leukemia.
    Tezuka M; Sugiyama H; Tamemasa O; Inaba M
    Gan; 1982 Feb; 73(1):70-6. PubMed ID: 7117749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
    Harada M; Nishitani H; Shirahama T; Koga K; Miura I
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of uracil on metabolism of 5-fluorouracil in vitro.
    Ikenaka K; Shirasaka T; Kitano S; Fujii S
    Gan; 1979 Jun; 70(3):353-9. PubMed ID: 467897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA synthesis in tumor-bearing rats.
    Shirasaka T; Fujii S
    Cancer Res; 1975 Mar; 35(3):517-20. PubMed ID: 1116120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the mechanism of cytotoxicity of 5-fluorouracil--through impairment of metabolism].
    Ikenaka K; Tanaka H; Kawai K; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):227-31. PubMed ID: 6349531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of 5-fluorouracil metabolism by thymidine. In vivo and in vitro studies on RNA-directed effects in rat liver and hepatoma.
    Engelbrecht C; Ljungquist I; Lewan L; Yngner T
    Biochem Pharmacol; 1984 Mar; 33(5):745-50. PubMed ID: 6201174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical differences in the tumor cells of 5-fluorouracil-sensitive and -resistant strains of Ehrlich ascitic carcinoma].
    Shlemkevich MP
    Biull Eksp Biol Med; 1983 Feb; 95(2):72-4. PubMed ID: 6824782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
    Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of enzyme activities involved in pyrimidine synthesis and its application to cancer chemotherapy].
    Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):760-8. PubMed ID: 6424581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin of increased deoxycytidine excretion into urine of rats bearing Yoshida ascites sarcoma.
    Shimizu M; Fujimura S
    Cancer Res; 1984 Jun; 44(6):2387-92. PubMed ID: 6722778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats.
    Shirasaka T; Shimamoto Y; Fukushima M
    Cancer Res; 1993 Sep; 53(17):4004-9. PubMed ID: 7689420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the combined effect of 5-fluorouracil and cyclophosphane on growth of Zajdela hepatoma and nucleic acid metabolism].
    Reztsova VV; Stukov AN; Filov VA
    Biull Eksp Biol Med; 1980 Oct; 90(10):469-71. PubMed ID: 7426710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA.
    Chu E; Lai GM; Zinn S; Allegra CJ
    Mol Pharmacol; 1990 Sep; 38(3):410-7. PubMed ID: 2402230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absorption, distribution and excretion of 3 H-chlorambucil in rats bearing the Yoshida ascites sarcoma.
    Hill BT; Riches PG
    Br J Cancer; 1971 Dec; 25(4):831-7. PubMed ID: 5144543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
    Roos G; Stenram U
    J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA synthesis in tumor-bearing rats: purification of liver thymidine kinase stimulating factor from Yoshida sarcoma.
    Harada N; Shirasaka T; Fujii S
    Gan; 1980 Apr; 71(2):173-80. PubMed ID: 7202914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.